SMMT — Summit Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeLarge CapHigh Flyer

Annual balance sheet for Summit Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 January 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	35.2	66.4	71.8	349	186
Net Total Accounts Receivable
Net Total Receivables	14.4	10.2	17.2	6.12	0.848
Prepaid Expenses
Total Other Current Assets
Total Current Assets	61.3	87.7	97.3	657	190
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	2.02	1.28	3.48	5.08	6.06
Net Goodwill
Net Intangible Assets
Long Term Notes Receivable
Other Long Term Assets
Total Assets	79.6	102	113	664	203
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	17.2	19.9	25.6	38.8	20.4
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	23.8	23	30.1	538	125
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	55.8	79.5	83.3	127	77.7
Total Liabilities & Shareholders' Equity	79.6	102	113	664	203
Total Common Shares Outstanding